Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M32,945Revenue (TTM) $M7,673Net Margin (%)-0.5Altman Z-Score1.5
Enterprise Value $M38,284EPS (TTM) $-0.0Operating Margin %-0.8Piotroski F-Score5
P/E(ttm)--Beneish M-Score-2.7Pre-tax Margin (%)-4.9Higher ROA y-yY
Price/Book5.110-y EBITDA Growth Rate %--Quick Ratio0.8Cash flow > EarningsY
Price/Sales4.35-y EBITDA Growth Rate %--Current Ratio1.2Lower Leverage y-yN
Price/Free Cash Flow50.2y-y EBITDA Growth Rate %--ROA % (ttm)-0.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-0.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M1,357ROIC % (ttm)1.7Gross Margin Increase y-yY

Gurus Latest Trades with BSX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BSXMichael Price 2016-03-31 Reduce-0.55%$16.07 - $18.82
($17.57)
$ 24.2838%Reduce -12.12%1,740,000
BSXVanguard Health Care Fund 2016-03-31 Reduce-0.03%$16.07 - $18.82
($17.57)
$ 24.2838%Reduce -1.38%63,222,390
BSXJohn Paulson 2016-03-31 Buy 0.01%$16.07 - $18.82
($17.57)
$ 24.2838%New holding74,000
BSXDodge & Cox 2016-03-31 Reduce$16.07 - $18.82
($17.57)
$ 24.2838%Reduce -5.19%427,430
BSXMario Gabelli 2016-03-31 Reduce$16.07 - $18.82
($17.57)
$ 24.2838%Reduce -3.13%796,046
BSXMario Gabelli 2015-12-31 Reduce$16.42 - $18.94
($17.96)
$ 24.2835%Reduce -2.96%821,746
BSXDodge & Cox 2015-12-31 Reduce$16.42 - $18.94
($17.96)
$ 24.2835%Reduce -4.68%450,830
BSXVanguard Health Care Fund 2015-09-30 Add0.16%$15.78 - $18.02
($17.1)
$ 24.2842%Add 7.52%64,108,690
BSXMario Gabelli 2015-09-30 Reduce-0.01%$15.78 - $18.02
($17.1)
$ 24.2842%Reduce -12.09%846,846
BSXDodge & Cox 2015-09-30 Reduce$15.78 - $18.02
($17.1)
$ 24.2842%Reduce -19.60%472,960
BSXMario Gabelli 2015-06-30 Reduce-0.03%$17.18 - $18.51
($17.87)
$ 24.2836%Reduce -26.90%963,296
BSXDodge & Cox 2015-06-30 Reduce$17.18 - $18.51
($17.87)
$ 24.2836%Reduce -19.36%588,260
BSXMario Gabelli 2015-03-31 Reduce-0.02%$13.22 - $18.07
($15.8)
$ 24.2854%Reduce -20.16%1,317,796
BSXDodge & Cox 2015-03-31 Reduce-0.01%$13.22 - $18.07
($15.8)
$ 24.2854%Reduce -38.43%729,460
BSXDodge & Cox 2014-12-31 Reduce-0.49%$11.37 - $13.68
($12.78)
$ 24.2890%Reduce -97.34%1,184,730
BSXVanguard Health Care Fund 2014-12-31 Add0.27%$11.37 - $13.68
($12.78)
$ 24.2890%Add 16.36%59,624,800
BSXLeon Cooperman 2014-09-30 Sold Out -1.1%$11.92 - $13.29
($12.59)
$ 24.2893%Sold Out0
BSXVanguard Health Care Fund 2014-09-30 Add0.25%$11.92 - $13.29
($12.59)
$ 24.2893%Add 19.88%51,242,050
BSXLeon Cooperman 2014-06-30 Reduce-0.35%$12.58 - $13.77
($13.01)
$ 24.2887%Reduce -23.25%6,549,479
BSXVanguard Health Care Fund 2014-06-30 Add0.2%$12.58 - $13.77
($13.01)
$ 24.2887%Add 16.19%42,743,200
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BSX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BSX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Pierce David ASVP and President, Endoscopy 2016-07-20Sell2,480$24.031.04view
Phalen Michael P.EVP & President, MedSurg 2016-07-20Sell35,000$24.031.04view
Ballinger Kevin J.SVP & Pres, Interven Cardio 2016-07-20Sell78,122$24.031.04view
Pratt Timothy A.EVP, GC & Chief Admin Officer 2016-06-01Sell24,229$22.667.15view
Mahoney Michael FPresident & CEO 2016-06-01Sell100,000$22.697.01view
Sorenson John BradleySVP, Manuf & Sup Chn 2016-05-11Sell2,800$22.159.62view
Dawkins Keith DEVP, Global Chief Med. Off. 2016-05-10Sell80,000$22.159.62view
Mirviss Jeffrey B.SVP&Pres, Periph Intervent 2016-05-06Sell24,659$21.9410.67view
Fitzgerald Joseph MichaelEVP & President, CRM 2016-05-03Sell79,960$21.8111.33view
Mahoney Michael FPresident & CEO 2016-05-02Sell100,000$22.129.76view

Press Releases about BSX :

Quarterly/Annual Reports about BSX:

News about BSX:

Articles On GuruFocus.com
Johnson & Johnson Reports 4% Sales Growth for the Second Quarter Jul 22 2016 
Weekly CEO Sells Highlight: Gilead Sciences, Boston Scientific, Sonic, HealthEquity Apr 10 2016 
Weekly CEO Sells Highlight: Motorcar Parts of America, The Interpublic Group of Companies, Gilead Sc Mar 07 2016 
The Best-Performing Stocks Among Vanguard Health Care Fund's Holdings Nov 04 2015 
Third Point's Third Quarter Letter Nov 02 2015 
Endo Pharmaceuticals Posts A Solid Q1 Earnings Report May 12 2015 
Vanguard Adds to Four of Its Largest Stakes May 04 2015 
Diamond Hill Select Fund Q4 2014 Commentary Mar 17 2015 
Boston Scientific Finally Wins Positive Nod For Watchman Heart Device In U.S. Leaving Investors Impr Mar 17 2015 
Endo International Shares Upbeat After Positive Q4 Earnings Report Mar 03 2015 

More From Other Websites
Boston Scientific (BSX) Stock Price Target Raised at Jefferies Jul 29 2016
Boston Scientific’s Stock Surged after 2Q16 Earnings Jul 29 2016
Boston Scientific’s 2Q16 Earnings Beat Analyst Estimates Jul 29 2016
Boston Scientific Sticks to Solo Strategy as Peers Consolidate Jul 29 2016
BOSTON SCIENTIFIC CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jul 28 2016
Boston Scientific (BSX) Meets Q2 Earnings Estimate, Views Up Jul 28 2016
Boston Scientific posts strong sales and boosts its outlook Jul 28 2016
Boston Scientific posts strong sales and boosts its outlook Jul 28 2016
3 Top-Rated Medical Device Stocks Beating Q2 Estimates Jul 28 2016
Boston Scientific raises full-year sales estimates again Jul 28 2016
Boston Scientific buys pain-management business, boosts its outlook Jul 28 2016
Boston Scientific (BSX) Stock Rises After Q2 Revenue Beat Jul 28 2016
Boston Scientific (BSX) Posts In-Line Q2 Earnings, View Up Jul 28 2016
Boston Scientific Corp Earnings Call scheduled for 8:00 am ET today Jul 28 2016
Boston Scientific Q2 Revenue Beats Guidance, Fueled By Deep Portfolio Jul 28 2016
Boston Scientific's sales beat on demand for heart devices Jul 28 2016
Q2 2016 Boston Scientific Corp Earnings Release - Before Market Open Jul 28 2016
Boston Scientific Announces Results For Second Quarter 2016 Jul 28 2016
6:46 am Boston Scientific reports EPS in-line, beats on revs; guides FY16 EPS in-line, revs above... Jul 28 2016
Boston Scientific reports higher sales on demand for heart devices Jul 28 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)